Gold nanoparticles improve effectiveness of medicines
Gold is an excellent candidate for nanomedicine because it is well tolerated by the body and is easily malleable
Keystone
Researchers at the University of Geneva (UNIGE), in collaboration with other institutions, have successfully highlighted the impact of gold nanoparticles on B lymphocytes.
This content was published on
2 minutes
Keystone-SDA/ts
These results, published in the journal ACS NanoExternal link, should pave the way for more effective vaccines and therapies.
B-cells are a crucial part of the immune system and thus an attractive target for vaccine development. However, to fulfil their goal, vaccines must reach B cells quickly without being destroyed en route, UNIGE said in a statement on Friday.
This is where the use of nanoparticles can be interesting.
“Nanoparticles can form a protective vehicle for vaccines – or other drugs – to specifically deliver them where they can be most effective, while sparing other cells,” explained Carole Bourquin, professor at UNIGE’s Faculties of Medicine and ScienceExternal link, who co-led the study.
“This targeting also allows the use of a lower dose of immunostimulant while maintaining an effective immune response. It increases its efficacy while reducing side-effects, provided that the nanoparticles are harmless to all immune cells.”
Golden opportunity
Gold is an excellent candidate for nanomedicine because of its particular physico-chemical properties, the authors wrote. Well tolerated by the body and easily malleable, this metal has, for instance, the particularity of absorbing light and then releasing heat, a property that can be exploited in oncology.
“Gold nanoparticles can be used to target tumours. When exposed to a light source, the nanoparticles release heat and destroy neighbouring cancer cells. We could also attach a drug to the surface of the nanoparticles to be delivered to a specific location,” said UNIGE researcher Sandra Hočevar.
The gold nanoparticles developed by the team of researchers could make it possible to deliver existing drugs directly to B lymphocytes to reduce the necessary dosage and potential side effects. In fact, studies in patients are already being carried out for the treatment of brain tumours, the researchers said.
More
More
Cancer in the crosshairs
This content was published on
Switzerland has joined an unprecedented scientific collaboration to accelerate nanomedicine testing in a bid to conquer a common enemy: cancer.
Swiss military jet crash: air traffic controller found guilty
This content was published on
Over eight and a half years after the fatal F/A-18 military jet accident in Switzerland, an air traffic controller has been found guilty of negligent homicide by a military appeals court.
Viola Amherd hands over keys of Swiss defence ministry to Martin Pfister
This content was published on
On Friday, the new Swiss government minister Martin Pfister was symbolically presented with the keys to the Federal Department of Defence, Civil Protection and Sport by outgoing minister Viola Amherd.
PostFinance cancels accounts of customers with Cuba links
This content was published on
The financial services arm of the Swiss post office, PostFinance, has cancelled the accounts of several customers with links to Cuba as a consequence of US sanctions against the Caribbean island state.
Basel cannabis study reports improvements in smokers’ mental health
This content was published on
After two years, a legal recreational cannabis study known as "Weedcare", carried out in Basel in northwestern Switzerland, has been given a positive assessment.
Group reports rise in anti-Semitic incidents in French-speaking Switzerland
This content was published on
Anti-Semitic incidents rose by almost 90% in French-speaking Switzerland last year, according to the Intercommunity Coordination Against Anti-Semitism and Defamation (known by its French name CICAD).
Number of Swiss around the world grew by 1.6% in 2024
This content was published on
Last year, 13,300 Swiss citizens moved abroad, taking the total number of Swiss Abroad to 826,700 (+1.6%). Three-quarters have more than one nationality, new figures show.
ICRC pleads for release of German nurse held in Somalia for seven years
This content was published on
The Geneva-based International Committee of the Red Cross (ICRC) has called for the release of Sonja Nientiet, one of its nurses who was kidnapped in Somalia in 2018.
This content was published on
A Swiss court says the cantonal authorities in Geneva should not have introduced a 30 km/h speed limit on its local roads.
Study finds nanoparticles in over one-quarter of foodstuffs
This content was published on
Nanoparticles were found in over one-quarter of the foodstuffs tested in a pilot study carried out in French-speaking Switzerland.
This content was published on
Lukas Novotny and his ETHZ collaborators at the Institute for Photonics manipulated a minuscule piece of glass only a hundred nanometres in size – a thousand times smaller than a hair – in such a way as to make it turn around its own axis more than a billion times a second. The results of…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.